Advancing delivery technologies for biologics and large molecules

The problem

Most animal health medicines are delivered systematically, leading to the need for larger doses, limited target range potential and off-target side effects

The solution

Pioneering the next generation of macromolecule delivery technologies to unlock the full therapeutic potential of biologics, oligonucleotides, and other large molecules

Our engagement